» Articles » PMID: 33447572

Dopamine Secreting Adrenal Tumor-ganglioneuroma Rather Than Pheochromocytoma: Case Report

Overview
Journal Gland Surg
Specialty Endocrinology
Date 2021 Jan 15
PMID 33447572
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Ganglioneuromas are rare, benign, well-differentiated neural crest tumors arising in the paravertebral sympathetic chain, and are classically non-secretory and clinically asymptomatic. As the diagnosis of ganglioneuroma is based on histopathology, the clinical presentation prior to surgical excision often mirrors that of pheochromocytoma or adrenal cortical adenoma. We describe a case of an incidentally found right sided calcified adrenal mass with evidence of marked dopamine excess, suspicious for pheochromocytoma in a 70-year-old female. The patient endorsed a 6-month history of intermittent right flank pain and a 2-year history of weight loss and fatigue. She reported mild symptoms of hypomania but denied other symptoms of dopamine excess including agitation, anxiety, nausea, and vomiting. Exam revealed isolated mild hypertension. The imaging features of this mass were concerning for malignancy including the presence of macrocalcification and irregular borders. After preoperative alpha blockade, the patient underwent open right adrenalectomy and the final pathology was consistent with ganglioneuroma rather than pheochromocytoma. Following resection, the dopamine level normalized, confirming the resected right adrenal ganglioneuroma as the source of dopamine excess. This case represents a rare presentation of dopamine-secreting adrenal ganglioneuroma. This illustrates that although rare, ganglioneuroma should be included on the differential diagnosis for functional adrenal tumors.

Citing Articles

Adrenocorticotropin-Secreting Pure Adrenal Ganglioneuroma Leading to Cushing Syndrome.

Alban D, Verma P, Kirschenbaum A, Fernandez-Ranvier G, Levine A JCEM Case Rep. 2025; 3(3):luaf027.

PMID: 39935496 PMC: 11809255. DOI: 10.1210/jcemcr/luaf027.


Adrenal ganglioneuroma: Prognostic factors (Review).

Sandru F, Dumitrascu M, Petca A, Carsote M, Petca R, Oproiu A Exp Ther Med. 2021; 22(5):1338.

PMID: 34630692 PMC: 8495554. DOI: 10.3892/etm.2021.10773.

References
1.
Erem C, Ucuncu O, Nuhoglu I, Cinel A, Cobanoglu U, Demirel A . Adrenal ganglioneuroma: report of a new case. Endocrine. 2009; 35(3):293-6. DOI: 10.1007/s12020-009-9180-4. View

2.
Zhou Y, Liang Q, Ou W, Li Z, Liu Q . Laparoscopic resection of primary adrenal ganglioneuroma: A case report and review of the literature. Oncol Lett. 2015; 9(5):2167-2170. PMC: 4467355. DOI: 10.3892/ol.2015.3021. View

3.
Diab D, Faiman C, Siperstein A, Zhou M, Zimmerman R . Virilizing adrenal ganglioneuroma in a woman with subclinical Cushing syndrome. Endocr Pract. 2008; 14(5):584-7. DOI: 10.4158/EP.14.5.584. View

4.
Adas M, Koc B, Adas G, Ozulker F, Aydin T . Ganglioneuroma presenting as an adrenal incidentaloma: a case report. J Med Case Rep. 2014; 8:131. PMC: 4031973. DOI: 10.1186/1752-1947-8-131. View

5.
Shawa H, Elsayes K, Javadi S, Morani A, Williams M, Lee J . Adrenal ganglioneuroma: features and outcomes of 27 cases at a referral cancer centre. Clin Endocrinol (Oxf). 2013; 80(3):342-7. DOI: 10.1111/cen.12320. View